<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: oncologists</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Study finds broad support for rationing of some types of cancer care</title>
   	 <description>The majority of cancer doctors, patients, and members of the general public support cutting health care costs by refusing to pay for drugs that don't improve survival or quality of life, according to results of a new study that will be presented by researchers from the Perelman School of Medicine at the University of Pennsylvania during the annual meeting of the American Society of Clinical Oncology in Chicago in early June (Abstract #6518).</description>
     <link>http://medicalxpress.com/news/2013-05-broad-rationing-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 15 May 2013 18:00:04 EST</pubDate>
	 <guid isPermaLink="false">news287856294</guid>
	 
</item>
<item>
     <title>Initiation of breast cancer treatment varies by race; patient-doctor communication is key</title>
   	 <description>Black women with breast cancer were found to be three times more likely than their white counterparts to delay treatment for more than 90 days—a time delay associated with increased deaths from the disease, according to a new study led by researchers at Georgetown Lombardi Comprehensive Cancer Center.</description>
     <link>http://medicalxpress.com/news/2013-05-breast-cancer-treatment-varies-patient-doctor.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 07 May 2013 12:37:05 EST</pubDate>
	 <guid isPermaLink="false">news287149018</guid>
	 
</item>
<item>
     <title>Two landmark studies report on success of using image-guided brachytherapy to treat cervical cancer</title>
   	 <description>Geneva, Switzerland: Two large, landmark radiotherapy studies have shown that it is possible to treat cervical cancer effectively with high doses specifically adapted to each tumour, and with fewer serious side-effects to the surrounding normal organs.</description>
     <link>http://medicalxpress.com/news/2013-04-landmark-success-image-guided-brachytherapy-cervical.html</link>
	 <category>Cancer</category>
	 <pubDate>Sat, 20 Apr 2013 07:02:09 EST</pubDate>
	 <guid isPermaLink="false">news285660021</guid>
	 
</item>
<item>
     <title>Mathematical models out-perform doctors in predicting cancer patients' responses to treatment</title>
   	 <description>Mathematical prediction models are better than doctors at predicting the outcomes and responses of lung cancer patients to treatment, according to new research presented today (Saturday) at the 2nd Forum of the European Society for Radiotherapy and Oncology (ESTRO).</description>
     <link>http://medicalxpress.com/news/2013-04-mathematical-out-perform-doctors-cancer-patients.html</link>
	 <category>Cancer</category>
	 <pubDate>Sat, 20 Apr 2013 06:54:06 EST</pubDate>
	 <guid isPermaLink="false">news285659630</guid>
	 
</item>
<item>
     <title>Individualized genomic testing allows for tailored cancer treatment, new drug research</title>
   	 <description>Just like a massive iceberg jutting out of the ocean, many of cancer's genetic underpinnings remain hidden under the surface, impossible to predict or map from above. The foreboding shadows and shapes that appear on CT scans and MRIs – and even in the field that doctors see when they zoom in to look at cancer cells under a high-powered microscope – are just the tip of the iceberg.</description>
     <link>http://medicalxpress.com/news/2013-04-individualized-genomic-tailored-cancer-treatment.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 05 Apr 2013 11:48:14 EST</pubDate>
	 <guid isPermaLink="false">news284381187</guid>
	 
</item>
<item>
     <title>Many cancer institution websites lack nutritional guidance, others give mixed messages</title>
   	 <description>Radiation oncologists at Thomas Jefferson University Hospital are stressing the need for evidence-based, standardized guidelines on dietary recommendations for cancer patients—and with good reason. A new analysis revealed that online dietary recommendations for cancer patients, if even present on an institution's website, appear to be consistently inconsistent.</description>
     <link>http://medicalxpress.com/news/2013-03-cancer-websites-lack-nutritional-guidance.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 26 Mar 2013 15:00:01 EST</pubDate>
	 <guid isPermaLink="false">news283522728</guid>
	 
</item>
<item>
     <title>'Toxicity map' of brain may help protect cognition for cancer patients</title>
   	 <description>New research from Wake Forest Baptist Medical Center is giving radiation oncologists who treat brain tumors a better understanding of how to preserve the brain's functions while still killing cancer.</description>
     <link>http://medicalxpress.com/news/2013-03-toxicity-brain-cognition-cancer-patients.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 20 Mar 2013 11:30:08 EST</pubDate>
	 <guid isPermaLink="false">news282997801</guid>
	 
</item>
<item>
     <title>American Academy of Microbiology releases resistance report</title>
   	 <description>What do cancer cells, weeds, and pathogens have in common? They all evolve resistance to the treatments that are supposed to eliminate them. However, researchers developing the next generation of antibiotics, herbicides, and anti-cancer therapeutics rarely come together to explore the common evolutionary principles at work across their different biological systems.</description>
     <link>http://medicalxpress.com/news/2013-03-american-academy-microbiology-resistance.html</link>
	 <category>Other</category>
	 <pubDate>Thu, 07 Mar 2013 10:24:36 EST</pubDate>
	 <guid isPermaLink="false">news281874267</guid>
	 
</item>
<item>
     <title>The right dose for oncology</title>
   	 <description>EPFL researchers develop a tool for oncologists using the electrical signature of cancer cells to get just the right treatment dosage for each patient.</description>
     <link>http://medicalxpress.com/news/2013-03-dose-oncology.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 04 Mar 2013 17:00:01 EST</pubDate>
	 <guid isPermaLink="false">news281616375</guid>
	 
</item>
<item>
     <title>Reassuring evidence: Anticancer drug does not accelerate tumor growth after treatment ends</title>
   	 <description>Studies in animals have raised concerns that tumors may grow faster after the anticancer drug sunitinib is discontinued. But oncologists and physicists who collaborated to analyze data from the largest study of patients with kidney cancer convincingly demonstrate that such tumor acceleration does not occur in humans. The findings, publishing online on February 7th in the Cell Press journal Cell Reports, suggest that sunitinib does not cause lingering risks for patients after their treatment ends.</description>
     <link>http://medicalxpress.com/news/2013-02-reassuring-evidence-anticancer-drug-tumor.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 07 Feb 2013 12:00:16 EST</pubDate>
	 <guid isPermaLink="false">news279458805</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/reassuringev.jpg" width="90" height="90" />
</item>
<item>
     <title>Tumors evolve rapidly in a childhood cancer, leaving fewer obvious tumor targets</title>
   	 <description>An extensive genomic study of the childhood cancer neuroblastoma reinforces the challenges in treating the most aggressive forms of this disease. Contrary to expectations, the scientists found relatively few recurrent gene mutations—mutations that would suggest new targets for neuroblastoma treatment. Instead, say the researchers, they have now refocused on how neuroblastoma tumors evolve in response to medicine and other factors.</description>
     <link>http://medicalxpress.com/news/2013-01-tumors-evolve-rapidly-childhood-cancer.html</link>
	 <category>Genetics</category>
	 <pubDate>Sun, 20 Jan 2013 13:00:27 EST</pubDate>
	 <guid isPermaLink="false">news277901484</guid>
	 
</item>
<item>
     <title>E-mail prompts improve code status documentation</title>
   	 <description>(HealthDay)—For patients with advanced lung cancer, prompting oncologists via e-mail successfully improved both the rate and timing of outpatient code status documentation in patients' electronic health records, according to research published online Jan. 2 in the Journal of Clinical Oncology.</description>
     <link>http://medicalxpress.com/news/2013-01-e-mail-prompts-code-status-documentation.html</link>
	 <category>Cancer</category>
	 <pubDate>Sat, 05 Jan 2013 10:40:13 EST</pubDate>
	 <guid isPermaLink="false">news276604806</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/emailprompts.jpg" width="90" height="90" />
</item>
<item>
     <title>Administering chemo ups income for non-salaried oncologists</title>
   	 <description>(HealthDay)—Non-salaried oncologists report the potential for increased salaries with the administration of chemotherapy or growth factors for lung or colorectal cancer patients, according to a study published online Dec. 26 in the Journal of Clinical Oncology.</description>
     <link>http://medicalxpress.com/news/2013-01-chemo-ups-income-non-salaried-oncologists.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 02 Jan 2013 13:20:01 EST</pubDate>
	 <guid isPermaLink="false">news276354371</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/administerin.jpg" width="90" height="90" />
</item>
<item>
     <title>One in four physicians uses social media daily</title>
   	 <description>A new survey shows that about one in four physicians uses social media daily or multiple times a day to scan or explore medical information, and 14 percent use social media each day to contribute new information, according to an oncologist at the Johns Hopkins Kimmel Cancer Center.</description>
     <link>http://medicalxpress.com/news/2012-12-physicians-social-media-daily.html</link>
	 <category>Health</category>
	 <pubDate>Mon, 10 Dec 2012 09:07:33 EST</pubDate>
	 <guid isPermaLink="false">news274352831</guid>
	 
</item>
<item>
     <title>New tumor tracking technique may improve outcomes for lung cancer patients</title>
   	 <description>Medical physicists at Thomas Jefferson University and Jefferson's Kimmel Cancer Center are one step closer to bringing a new tumor-tracking technique into the clinic that delivers higher levels of radiation to moving tumors, while sparing healthy tissue in lung cancer patients.</description>
     <link>http://medicalxpress.com/news/2012-11-tumor-tracking-technique-outcomes-lung.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 19 Nov 2012 15:59:04 EST</pubDate>
	 <guid isPermaLink="false">news272563126</guid>
	 
</item>
<item>
     <title>Oncologists generally refer to specialized palliative care late</title>
   	 <description>(HealthDay)—Definitional issues and non-acceptance of patients receiving chemotherapy are the barriers to earlier referral to specialized palliative care (SPC) by oncologists, according to a study published online Oct. 29 in the Journal of Clinical Oncology.</description>
     <link>http://medicalxpress.com/news/2012-10-oncologists-specialized-palliative-late.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 30 Oct 2012 16:20:01 EST</pubDate>
	 <guid isPermaLink="false">news270831717</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/oncologistsg.jpg" width="90" height="90" />
</item>
<item>
     <title>Cancer survivors prefer to stay with cancer doctors: study</title>
   	 <description>(HealthDay)—Even after cancer patients beat their disease, many still grapple with health issues related to their treatments, including cardiovascular and bone problems. But, survivors often say it's unclear which doctor to turn to for follow-up care.</description>
     <link>http://medicalxpress.com/news/2012-09-cancer-survivors-doctors.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 13 Sep 2012 20:30:01 EST</pubDate>
	 <guid isPermaLink="false">news266782971</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/cancersurviv.jpg" width="90" height="90" />
</item>
<item>
     <title>Exercise can help cancer patients, but few oncologists suggest it</title>
   	 <description>Numerous studies have shown the powerful effect that exercise can have on cancer care and recovery. For patients who have gone through breast or colon cancer treatment, regular exercise has been found to reduce recurrence of the disease by up to 50 percent. But many cancer patients are reluctant to exercise, and few discuss it with their oncologists, according to a Mayo Clinic study published in the Journal of Pain and Symptom Management.</description>
     <link>http://medicalxpress.com/news/2012-08-cancer-patients-oncologists.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 28 Aug 2012 14:38:00 EST</pubDate>
	 <guid isPermaLink="false">news265383474</guid>
	 
</item>
<item>
     <title>Many options, good outcomes, for early-stage follicular lymphoma</title>
   	 <description>(Medical Xpress) -- A University of Rochester Medical Center study challenges treatment guidelines for early stage follicular lymphoma, concluding that six different therapies can bring a remission, particularly if the patient is carefully examined and staged at diagnosis.</description>
     <link>http://medicalxpress.com/news/2012-08-options-good-outcomes-early-stage-follicular.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 21 Aug 2012 15:08:34 EST</pubDate>
	 <guid isPermaLink="false">news264780498</guid>
	 
</item>
<item>
     <title>Modification of tumor suppressor affects sensitivity to potential GBM treatment</title>
   	 <description>Despite years of research, glioblastoma, the most common and deadly brain cancer in adults, continues to outsmart treatments targeted to inhibit tumor growth.</description>
     <link>http://medicalxpress.com/news/2012-08-modification-tumor-suppressor-affects-sensitivity.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 13 Aug 2012 16:12:10 EST</pubDate>
	 <guid isPermaLink="false">news264093122</guid>
	 
</item>
<item>
     <title>UC Irvine studies therapy robot's effect on chemo patients</title>
   	 <description>(Medical Xpress) -- Oncologists at UC Irvine Medical Center are pairing robotic baby harp seals with women receiving chemotherapy to study whether the cuddly mechanical creatures can ease pain and stress.</description>
     <link>http://medicalxpress.com/news/2012-08-uc-irvine-therapy-robot-effect.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 02 Aug 2012 08:12:08 EST</pubDate>
	 <guid isPermaLink="false">news263113915</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/ucirvinestud.jpg" width="90" height="90" />
</item>
<item>
     <title>Cancer docs often deal with own grief, doubts when patients die</title>
   	 <description>(HealthDay) -- Some cancer doctors may build up emotional walls -- distancing themselves from the patients they can't save -- to avoid grief, sadness and even despair, new research shows.</description>
     <link>http://medicalxpress.com/news/2012-05-cancer-docs-grief-patients-die.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 23 May 2012 13:50:01 EST</pubDate>
	 <guid isPermaLink="false">news256998497</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/cancerdocsof.jpg" width="90" height="90" />
</item>
<item>
     <title>Accelerated chemotherapy given before surgery benefits patients with muscle-invasive bladder cancer</title>
   	 <description>For some patients with muscle-invasive bladder cancer, treatment may begin before they undergo cystectomy, or surgical removal of the bladder. They may be advised by oncologists to receive chemotherapy before surgery. A large randomized clinical trial published in 2003 demonstrated a survival benefit for neoadjuvant, or pre-surgical, MVAC (methotrexate, vinblastine, doxorubicin and cisplatin) using a standard dose and schedule. However, in an effort to improve toxicity, standard MVAC has been essentially abandoned in favor of other regimens. All current standard neoadjuvant regimens require 12 weeks of chemotherapy.</description>
     <link>http://medicalxpress.com/news/2012-05-chemotherapy-surgery-benefits-patients-muscle-invasive.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 17 May 2012 09:46:56 EST</pubDate>
	 <guid isPermaLink="false">news256466808</guid>
	 
</item>
<item>
     <title>Many primary care docs don't know long-term effects of chemo: survey</title>
   	 <description>(HealthDay) -- Many primary care doctors don't know the long-term side effects of the chemotherapy treatments that cancer survivors under their care may have been given, a new survey found.</description>
     <link>http://medicalxpress.com/news/2012-05-primary-docs-dont-long-term-effects.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 17 May 2012 06:00:01 EST</pubDate>
	 <guid isPermaLink="false">news256450550</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/manyprimaryc.jpg" width="90" height="90" />
</item>
<item>
     <title>What price for a year of life? Cancer specialists offer contradictory advice</title>
   	 <description>Cancer doctors prescribe medicines with little consideration of the cost, meaning they don't demand any more benefit (in months of survival) from a very expensive drug than from a less expensive one, a new research report says.  </description>
     <link>http://medicalxpress.com/news/2012-04-price-year-life-cancer-specialists.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 20 Apr 2012 03:55:45 EST</pubDate>
	 <guid isPermaLink="false">news254112933</guid>
	 
</item>
<item>
     <title>Breast cancer patients choosing surgery without learning their options</title>
   	 <description>Surgeons are not always including radiation oncologists early enough in a patient's treatment decision-making process, leaving some patients uninformed of all of their treatment options and potentially leading to more mastectomies over breast-conserving therapy, according to a study in the April issue of the International Journal of Radiation Oncology&amp;#149;Biology&amp;#149;Physics, the official scientific journal of the American Society for Radiation Oncology (ASTRO).</description>
     <link>http://medicalxpress.com/news/2012-04-breast-cancer-patients-surgery-options.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 18 Apr 2012 11:47:32 EST</pubDate>
	 <guid isPermaLink="false">news253968445</guid>
	 
</item>
<item>
     <title>Cancer patients under-referred for orthopedic oncology services</title>
   	 <description>There is a disconnect between the number of cancer patients estimated to have bone metastases and the number of patients who are sent for orthopedic care each year, states an article in the Canadian Journal of Surgery (CJS).</description>
     <link>http://medicalxpress.com/news/2012-04-cancer-patients-under-referred-orthopedic-oncology.html</link>
	 <category>Surgery</category>
	 <pubDate>Mon, 02 Apr 2012 11:02:36 EST</pubDate>
	 <guid isPermaLink="false">news252583350</guid>
	 
</item>
<item>
     <title>Radiation oncologists are discussing infertility risks with young cancer patients</title>
   	 <description>More than 80 percent of radiation oncologists discuss the impact of cancer treatments on fertility with their patients of childbearing age, which can lead to improved quality of life for young cancer patients who are living much longer after their original diagnosis thanks to modern treatment options, according to a study in Practical Radiation Oncology (PRO), the official clinical practice journal of the American Society for Radiation Oncology (ASTRO).</description>
     <link>http://medicalxpress.com/news/2012-03-oncologists-discussing-infertility-young-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 08 Mar 2012 15:00:07 EST</pubDate>
	 <guid isPermaLink="false">news250441199</guid>
	 
</item>
<item>
     <title>Scientists uncover mechanism for melanoma drug resistance</title>
   	 <description>Cancer is tough to kill and has many ways of evading the drugs used by oncologists to try and eliminate it.</description>
     <link>http://medicalxpress.com/news/2012-03-scientists-uncover-mechanism-melanoma-drug.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 06 Mar 2012 11:16:51 EST</pubDate>
	 <guid isPermaLink="false">news250254999</guid>
	 
</item>
<item>
     <title>Project to improve radiotherapy planning</title>
   	 <description>A collaborative project between physicists, oncologists and computer scientists at Oxford and Cambridge Universities, launched last month, will develop improved tools for the planning of high precision radiotherapy. Accel-RT will also help overcome time constraints that currently limit the use of complex radiotherapy treatment.</description>
     <link>http://medicalxpress.com/news/2012-01-radiotherapy.html</link>
	 <category>Other</category>
	 <pubDate>Mon, 30 Jan 2012 08:30:01 EST</pubDate>
	 <guid isPermaLink="false">news247133652</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/projecttoimp.jpg" width="90" height="90" />
</item>


</channel>
</rss>
